Ask Warren

Bio Solution

086820 · KOSDAQ · ₩086820 · 바이오솔루션

₩5,650▲ ₩60 (1.07%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩4.7B₩3.8B₩4.4B₩4.5B₩3.1B₩3.1B₩3.6B₩3.4B
Cost of sales₩1.4B₩1.3B₩1.5B₩1.7B₩1.3B₩1.1B₩1.1B₩1.3B
Gross profit₩3.3B₩2.5B₩2.9B₩2.8B₩1.8B₩2B₩2.4B₩2.1B
Operating income−₩482M−₩1.3B−₩485M−₩1.1B−₩1.4B−₩1.4B−₩476M−₩1.3B
Net income₩1.3B−₩2B₩2.1B−₩906M₩1.5B−₩2.4B−₩9.3B−₩1.9B
Net income to shareholders−₩736M−₩2B₩5.5B−₩1.9B−₩950M−₩2.4B−₩9.3B−₩1.9B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩66B₩66B₩68B₩63B₩63B₩65B₩67B₩72B
Current assets₩19B₩18B₩19B₩19B₩18B₩19B₩21B₩21B
Cash and equivalents₩9.3B₩11B₩12B₩12B₩12B₩13B₩13B₩8.5B
Total liabilities₩25B₩24B₩36B₩36B₩35B₩36B₩36B₩35B
Current liabilities₩22B₩22B₩34B₩34B₩33B₩33B₩33B₩33B
Borrowings₩19B₩18B₩29B₩28B₩28B₩27B₩26B₩26B
Total equity₩41B₩42B₩32B₩26B₩28B₩29B₩31B₩36B
Shareholders' equity₩41B₩42B₩32B₩26B₩28B₩29B₩31B₩36B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩312M−₩621M₩246M₩17M−₩863M−₩711M₩255M−₩779M
Capital spending₩59M₩57M₩15M₩22M₩146M₩1.8M₩70M₩24M
Free cash flow₩253M−₩679M₩230M−₩4.7M−₩1B−₩713M₩185M−₩803M

Consolidated where available. Amounts in won.

Also known as: Bio Solution / 바이오솔루션 / 086820 / KRX:086820

Source: KRX statistical information